Prot #c16-168: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects

Project: Research project

Project Details

StatusActive
Effective start/end date11/11/1611/11/22

Funding

  • Prostate Cancer Clinical Trials Consortium, LLC (Prot #c16-168)
  • AstraZeneca Pharmaceuticals LP (Prot #c16-168)